Efficacy of ranibizumab in patients with macular edema secondary to central retinal vein occlusion: Results from the sham-controlled ROCC study

American Journal of Ophthalmology

Volumn 150, Issue 3, 2010, Pages 310-314

  Kinge, Bettina ^a   Stordahl, Per Bjørn ^a   Forsaa, Vegard ^b   Fossen, Kristian ^c   Haugstad, Marta ^d   Helgesen, Ole Harald ^c   Seland, Johan ^b   Stene Johansen, Ingar ^d  

^a Retinaklinikken Aleris   (Norway)

^b University Hospital   (Norway)

^c UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; RANIBIZUMAB;

ADULT; AGED; ARTERY THROMBOSIS; ARTICLE; CENTRAL RETINA VEIN OCCLUSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; INTRAOCULAR HEMORRHAGE; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA EDEMA; RETINA TEAR; SHAM PROCEDURE; TREATMENT OUTCOME; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETINAL VEIN OCCLUSION; RETREATMENT; TREATMENT OUTCOME; VISUAL ACUITY; VITREOUS BODY;

EID: 77955910514     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2010.03.028     Document Type: Article

References (19)

1. S. Arvas, O. Ocakoglu, and S. Ozkan The capillary blood flow in ischaemic type central retinal vein occlusion: the effect of laser photocoagulation Acta Ophthalmol Scand 80 5 2002 490 494
2. The Central Vein Occlusion Study Group N Report A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion Ophthalmology 102 10 1995 1434 1444
3. L.M. Smithen, M.D. Ober, L. Maranan, and R.F. Spaide Intravitreal triamcinolone acetonide and intraocular pressure Am J Ophthalmol 138 5 2004 740 743
4. S. Kaushik, V. Gupta, A. Gupta, M.R. Dogra, and R. Singh Intractable glaucoma following intravitreal triamcinolone in central retinal vein occlusion Am J Ophthalmol 137 4 2004 758 760
5. O. Cekic, S. Chang, and J.J. Tseng Cataract progression after intravitreal triamcinolone injection Am J Ophthalmol 139 6 2005 993 998
6. S.S. Hayreh Classification of central retinal vein occlusion Ophthalmology 90 5 1983 458 474
7. The Central Vein Occlusion Study Group Natural history and clinical management of central retinal vein occlusion Arch Ophthalmol 115 4 1997 486 491
8. L.P. Aiello, R.L. Avery, and P.G. Arrigg Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders N Engl J Med 331 22 1994 1480 1487
9. S.R. Boyd, I. Zachary, and U. Chakvarthy Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion Arch Ophthalmol 120 12 2002 1644 1650
10. M.J. Tolentino, J.W. Miller, and E.S. Gragoudas Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate Ophthalmology 103 11 1996 1820 1828
11. D. Itturalde, R.F. Spaide, and C.B. Meyerle Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study Retina 26 3 2006 279 284
12. R.A. Costa, R. Jorge, and D. Calucci Intravitreal bevacizumab (Avastin) for central and hemicentral retinal vein occlusions: IBeVO Study Retina 27 2 2007 141 149
13. D.C. Ferrara, H. Koizumi, and R.F. Spaide Early bevacizumab treatment of central retinal vein occlusion Am J Ophthalmol 144 6 2007 864 871 (Pubitemid 350122344)
14. Q.D. Nguyen, S. Tatlipinar, and S.M. Shah Vascular endothelial growth factor is a critical stimulus for diabetic macular edema Am J Ophthalmol 142 6 2006 961 969
15. D.W. Chun, J.S. Heier, and T.M. Topping A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema Ophthalmology 113 10 2006 1706 1712
16. R.F. Spaide, L.K. Chang, and J.M. Klancnik Prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion Am J Ophthalmol 147 2 2009 298 306
17. D.J. Pieramici, M. Rabena, and A.A. Castellarin Ranibizumab for the treatment of macular edema associated with perfused central retinal vein occlusions Ophthalmology 115 10 2008 e47 e54
18. F. Prager, S. Michels, and K. Kriechbaum Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial Br J Ophthalmol 93 4 2009 452 456
19. T. von Hanno, B. Kinge, and K. Fossen Retinal artery occlusion following intravitreal anti-VEGF therapy Acta Ophthalmol 88 2 2010 263 266